Sponsor Pipeline

GOG Foundation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Phase 3
4
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
TrialChangesDetected
NCT04831580
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer		 critical
  • Primary completion pushed: 2028-08 -> 2029-03
  • Trial sites expanded: 136 -> 156 locations
  • Completion pushed: 2029-08 -> 2030-03
 2026-07-31
NCT05649956
Letrozole in Uterine Leiomyosarcoma · Phase 2
  • Trial sites expanded: 25 -> 34 locations
 2026-07-31
NCT05154487
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer · Phase 2
  • Trial sites expanded: 18 -> 21 locations
 2026-07-31
Active Trials by Phase
Phase 2
3
Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05659381 Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal… Stage III Ovarian Cancer Recruiting
Phase 2
NCT05649956 Letrozole in Uterine Leiomyosarcoma Uterine Leiomyosarcoma Recruiting
NCT07672782 Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva Vulvar Carcinoma Not Yet Recruiting
NCT05154487 A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer Endometroid Endometrial Cancer Active, Not Recruiting
Not specified
NCT04831580 A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer Cervical Cancer Recruiting
Disease Areas
Cervical Cancer (1) Endometrial Cancer (1) Sarcoma (1) Ovarian Cancer (1)
Get alerts when GOG Foundation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free